Elevation Oncology, Inc. - stock earnings
ELEV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -7.9 million USD | ? USD |
| 2023Q3 | -10.6 million USD | ? USD |
| 2023Q2 | -10.1 million USD | ? USD |
| 2023Q1 | -17.1 million USD | ? USD |
| 2022Q4 | -19.0 million USD | ? USD |
| 2022Q3 | -39.1 million USD | ? USD |
| 2022Q2 | -19.7 million USD | ? USD |
| 2022Q1 | -17.2 million USD | ? USD |
| 2021Q4 | -9.6 million USD | ? USD |
| 2021Q3 | -12.3 million USD | ? USD |
| 2021Q2 | -5.1 million USD | ? USD |
| 2021Q1 | -5.1 million USD | ? USD |
| 2020Q4 | -8.9 million USD | ? USD |
| 2020Q3 | -3.0 million USD | ? USD |
| 2020Q2 | -3.4 million USD | ? USD |
| 2020Q1 | -2.0 million USD | ? USD |
ELEV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -45.7 million USD | ? USD |
| 2022 | -95.1 million USD | ? USD |
| 2021 | -32.0 million USD | ? USD |
| 2020 | -17.3 million USD | ? USD |
| 2019 | -5.9 million USD | ? USD |
ELEV
Price: $3.82
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -1.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 9000
Market Capitalization: 230.1 million